{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:09:44Z","timestamp":1788473384796,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10067-021-05962-7","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T06:03:11Z","timestamp":1634796191000},"page":"705-708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Seroconversion of rheumatoid arthritis patients after yellow fever vaccination"],"prefix":"10.1007","volume":"41","author":[{"given":"Betina Soares","family":"dos Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Cintra","family":"Staub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Koishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Zanluca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Nunes Duarte","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thelma L.","family":"Skare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Stadler","family":"Kahlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"issue":"6","key":"5962_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3201\/eid2706.204170","volume":"27","author":"AF Ribeiro","year":"2021","unstructured":"Ribeiro AF, Guedes BF, Sulleiman JMAH, de Oliveira FTM, de Souza IOM, Nogueira JS et al (2021) Neurologic disease after yellow fever vaccination, S\u00e3o Paulo, Brazil, 2017\u20132018. Emerg Infect Dis 27(6):1577\u20131587. https:\/\/doi.org\/10.3201\/eid2706.204170","journal-title":"Emerg Infect Dis"},{"key":"5962_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2014.08.030","volume":"64","author":"TP Monath","year":"2015","unstructured":"Monath TP, Vasconcelos PFC (2015) Yellow fever. J Clin Virol 64:160\u201373. https:\/\/doi.org\/10.1016\/j.jcv.2014.08.030","journal-title":"J Clin Virol"},{"issue":"10","key":"5962_CR3","doi-asserted-by":"publisher","first-page":"e180278","DOI":"10.1590\/0074-02760180278","volume":"113","author":"C Possas","year":"2018","unstructured":"Possas C, Louren\u00e7o-de-Oliveira R, Tauil PL, Pinheiro FP, Pissinatti A, Cunha RVD et al (2018) Yellow fever outbreak in Brazil: the puzzle of rapid viral spread and challenges for immunization. Mem Inst Oswaldo Cruz 113(10):e180278. https:\/\/doi.org\/10.1590\/0074-02760180278","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5962_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","volume":"38","author":"LAB Camacho","year":"2004","unstructured":"Camacho LAB, Freire MS, Leal ML, Aguiar SG, Nascimento JP, Iguchi T, Collaborative Group for the Study of Yellow Fever Vaccines et al (2004) Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial. Rev Saude Publica 38:671\u20138. https:\/\/doi.org\/10.1590\/S0034-89102004000500009","journal-title":"Rev Saude Publica"},{"issue":"2","key":"5962_CR5","doi-asserted-by":"publisher","first-page":"e001041","DOI":"10.1136\/rmdopen-2019-001041","volume":"5","author":"V Furer","year":"2019","unstructured":"Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N et al (2019) Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD. RMD Open 5(2):e001041. https:\/\/doi.org\/10.1136\/rmdopen-2019-001041 (eCollection 2019)","journal-title":"RMD Open"},{"key":"5962_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","volume":"26","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Manta KG, Betsi GI, Pappas G (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26:663\u2013670. https:\/\/doi.org\/10.1007\/s10067-006-0441-9","journal-title":"Clin Rheumatol"},{"issue":"11","key":"5962_CR7","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/14712598.2016.1218844","volume":"16","author":"S Fernandez-Martinez","year":"2016","unstructured":"Fernandez-Martinez S, Cortes X, Borr\u00e1s-Blasco J, Gracia-P\u00e9rez A, Caster\u00e1 ME (2016) Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs. Expert Opin Biol Ther 16(11):1317\u20131322. https:\/\/doi.org\/10.1080\/14712598.2016.1218844","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"5962_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M et al (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79(1):39\u201352. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215882","journal-title":"Ann Rheum Dis"},{"key":"5962_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s42358-019-0056-x","volume":"59","author":"GS Pileggi","year":"2019","unstructured":"Pileggi GS, Da Mota LMH, Kakehasi AM, De Souza AW, Rocha A, de Melo AKG et al (2019) Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases. Adv Rheumatol 59:17. https:\/\/doi.org\/10.1186\/s42358-019-0056-x","journal-title":"Adv Rheumatol"},{"key":"5962_CR10","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3389\/fimmu.2020.01382","volume":"11","author":"V Valim","year":"2020","unstructured":"Valim V, Machado KLLL, Miyamoto ST, Pinto AD, Rocha PCM, Serrano EV et al (2020) Planned yellow fever primary vaccination is safe and immunogenic in patients with autoimmune diseases: a prospective non-interventional study. Front Immunol 11:1382. https:\/\/doi.org\/10.3389\/fimmu.2020.01382 (eCollection 2020)","journal-title":"Front Immunol"},{"issue":"6","key":"5962_CR11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/acr.20045","volume":"62","author":"M Scheinberg","year":"2010","unstructured":"Scheinberg M, Guedes-Barbosa LS, Mangueira C, Rosseto EA, Mota L, Oliveira AC et al (2010) Yellow fever revaccination during infliximab therapy. Arthritis Care Res (Hoboken) 62(6):896\u2013898. https:\/\/doi.org\/10.1002\/acr.20045","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"5962_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/art.38960","volume":"67","author":"ACV Oliveira","year":"2015","unstructured":"Oliveira ACV, Mota LMH, Santos-Neto LL, Sim\u00f5es M, Martins-Filho OA, Tauil PL (2015) Seroconversion in patients with rheumatic diseases treated with immunomodulators or immunosuppressants, who were inadvertently revaccinated against yellow fever. Arthritis Rheumatol 67(2):582\u2013583. https:\/\/doi.org\/10.1002\/art.38960","journal-title":"Arthritis Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05962-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05962-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05962-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T03:10:16Z","timestamp":1645758616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05962-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5962"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05962-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Committee of Ethics in Research 4.221.307 from Mackenzie Evangelic School of Medicine, PR, Brazil.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}